CHM 5.88% 1.6¢ chimeric therapeutics limited

CHIMERIC THERAPEUTICS LIMITED IPO Analysis, page-103

  1. 96 Posts.
    lightbulb Created with Sketch. 94
    A couple of things worth mentioning:

    1) if CHM's technology is a sure thing, PH wouldn't have listed the company but rather kept it to himself like what he did with IMU's Vaxinia. Listing CHM is about balancing PH's risks and obviously he didn't have 100% or even 80% conviction that this thing will work let alone reach market.

    2) None of the products to which PH has been associated with has ever become a product and released to the market. All are in clinical trials...still. (source: recent Eureka Report interview where AK asked PH this direct question).

    The market cap and share price of CHM is simply flying blind at the moment until the market receive update/result from phase 1 clinical trial.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.6¢
Change
-0.001(5.88%)
Mkt cap ! $14.29M
Open High Low Value Volume
1.7¢ 1.7¢ 1.6¢ $27.84K 1.733M

Buyers (Bids)

No. Vol. Price($)
9 1060707 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 239000 2
View Market Depth
Last trade - 16.10pm 03/09/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.